INTRO:
The Serum Institute of India has applied for emergency use authorisation in the country for AstraZeneca's Covid-19 vaccine, which it is manufacturing locally.
This comes after Pfizer on Saturday is understood to have applied for a similar authorisation.
India added almost 33,000 new Covid-19 infections in 24 hours on Monday, according to health ministry figures, bringing its total to close to 9.7 million confirmed cases.
Our correspondent Rebecca Bundhun reports from Mumbai.
IN: "Serum Institute of India …"
OUT: SOC
DUR: 32 secs
GENERIC: http://www.fsnradionews.com/feeds/1207Indiavaccine-rb-generic.mp3
The Serum Institute of India has applied for emergency use authorisation in the country for AstraZeneca's Covid-19 vaccine, which it is manufacturing locally.
This comes after Pfizer on Saturday is understood to have applied for a similar authorisation.
India added almost 33,000 new Covid-19 infections in 24 hours on Monday, according to health ministry figures, bringing its total to close to 9.7 million confirmed cases.
Our correspondent Rebecca Bundhun reports from Mumbai.
IN: "Serum Institute of India …"
OUT: SOC
DUR: 32 secs
GENERIC: http://www.fsnradionews.com/feeds/1207Indiavaccine-rb-generic.mp3